1 / 9

Global mRNA Technology Market | RationalStat

The global mRNA technology market is expected to exhibit a marginal growth rate of 1.8% during the forecast period of 2022-2030. One of the major factors driving the market growth is the increased prevalence of medical disorders such as diabetes, tuberculosis (TB), cancer, and cardiovascular diseases (CVDs). The industry is also benefiting from the rising demand for therapeutic drugs and vaccines for COVID-19, Ebola, influenza, infectious and chronic diseases such as HIV, and other viral illnesses.

JamesHenderson1819
Download Presentation

Global mRNA Technology Market | RationalStat

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Published Nov 2022 Report: Global mRNA Technology Market Investment, Market Size & Forecast, 2020-2030 info@rationalstat.com | rationalstat.com

  2. Global mRNA Technology Market Investment, Market Size & Forecast, 2020-2030 Table of Contents 1.Market Introduction 1.1.Scope of Study 1.2.Problem Statement 1.3.Market Segmentation 2.Assumptions and Acronyms 3.Executive Summary 3.1.Global Market in 2022 3.2.Analyst Insights & Recommendations 3.3.Growth Opportunities and Key Strategies 3.4.Supply-side and Demand-side Trends 4.Research Methodology 5.Analysis of COVID-19 Impact and Road Ahead 5.1.Impact on Growth Strategies 5.2.Impact on Operations and Supply Chain 5.3.Impact on Roll-outs Plans 6.Market Indicators and Background 6.1.Macro-Economic Factors 6.2.Forecasting Factors Robust assessment of various factors including industrial performance, industry players’ expenditures, and economic conditions, among others 6.3.Supply Chain & Value Chain Analysis 6.3.1. mRNA Technology Providers 6.3.2. Key End User 6.4.Industry SWOT Analysis 6.5.PESTLE Analysis 6.6.Porter’s Five Forces Analysis 7.Rules & Regulations 8.Global and Regional Market Dynamics 8.1.Drivers 8.2.Restraints 8.3.Trends 8.4.Opportunities 9.Global mRNA Technology Industry: Key Investment and Development Analysis 9.1.By Leading Providers 9.2.By Region 9.3.By Product 9.4.By Application 9.5.M&A Activities Robust assessment of major investments made by various industry players along with key application areas, and key regions 10.Market Spending & Use Case Analysis 11.Product/Drug Pipeline Analysis 11.1.By Key Players 11.2.By Product Click here to purchase online!

  3. Global mRNA Technology Market Investment, Market Size & Forecast, 2020-2030 11.3.By Application 11.4.By Region 12.Clinical Trials Analysis Exhaustive list of all the clinical trials sponsored by various industry players based on the technology will be provided. Moreover, it would also categorize the trials into IND submissions, Phase I, Phase II etc. 13.Parent Market Overview: Global Healthcare & Life Sciences Market 14.Segmental Analysis 14.1.Global mRNA Technology Market by Product 14.1.1. Segment Overview 14.1.1.1. Prophylactic Vaccines 14.1.1.2. Therapeutic Vaccines 14.1.1.3. Therapeutics 14.2.Global mRNA Technology Market by Manufacturing 14.2.1. Segment Overview 14.2.1.1. In-House 14.2.1.2. Outsourced 14.3.Global mRNA Technology Market by Application 14.3.1.Segmental Overview 14.3.1.1. Oncology 14.3.1.2. Respiratory Diseases 14.3.1.3. Infectious Diseases 14.3.1.4. Rare Diseases 14.3.1.5. Others (Coronary Artery Diseases etc.) 14.4.Global mRNA Technology Market by End User 14.4.1. Segment Overview 14.4.1.1. Hospitals and Clinics 14.4.1.2. Academic & Research Institutions 14.5.Global mRNA Technology Market by Region 14.5.1.Segment Overview 14.5.1.1. North America 14.5.1.2. Latin America 14.5.1.3. Western Europe 14.5.1.4. Eastern Europe 14.5.1.5. Asia Pacific 14.5.1.6. Middle East & Africa 15.Regional Analysis 15.1.North America mRNA Technology Market Analysis and Forecast 2020-2030 15.1.1.Regional Market Overview and Key Takeaways 15.1.2.North America mRNA Technology Market by Product 15.1.3.North America mRNA Technology Market by Manufacturing 15.1.4.North America mRNA Technology Market by Application 15.1.5.North America mRNA Technology Market by End User 15.1.6.North America mRNA Technology Market by Country 15.1.6.1. US 15.1.6.2. Canada 15.2.Latin America mRNA Technology Market Analysis and Forecast 2020-2030 15.2.1.Regional Market Overview and Key Takeaways 15.2.2.Latin America mRNA Technology Market by Product Click here to purchase online!

  4. Global mRNA Technology Market Investment, Market Size & Forecast, 2020-2030 15.2.3.Latin America mRNA Technology Market by Manufacturing 15.2.4.Latin America mRNA Technology Market by Application 15.2.5.Latin America mRNA Technology Market by End User 15.2.6.Latin America mRNA Technology Market by Country 15.2.6.1. Brazil 15.2.6.2. Mexico 15.2.6.3. Rest of Latin America 15.3.Western Europe mRNA Technology Market Analysis and Forecast 2020-2030 15.3.1.Regional Market Overview and Key Takeaways 15.3.2.Western Europe mRNA Technology Market by Product 15.3.3.Western Europe mRNA Technology Market by Manufacturing 15.3.4.Western Europe mRNA Technology Market by Application 15.3.5.Western Europe mRNA Technology Market by End User 15.3.6.Western Europe mRNA Technology Market by Country 15.3.6.1. Germany 15.3.6.2. UK 15.3.6.3. France 15.3.6.4. Spain 15.3.6.5. Italy 15.3.6.6. Benelux 15.3.6.7. Nordic 15.3.6.8. Rest of Western Europe 15.4.Eastern Europe mRNA Technology Market Analysis and Forecast 2020-2030 15.4.1.Regional Market Overview and Key Takeaways 15.4.2.Eastern Europe mRNA Technology Market by Product 15.4.3.Eastern Europe mRNA Technology Market by Manufacturing 15.4.4.Eastern Europe mRNA Technology Market by Application 15.4.5.Eastern Europe mRNA Technology Market by End User 15.4.6.Eastern Europe mRNA Technology Market by Country 15.4.6.1. Russia 15.4.6.2. Poland 15.4.6.3. Rest of Eastern Europe 15.5.Asia Pacific mRNA Technology Market Analysis and Forecast 2020-2030 15.5.1.Regional Market Overview and Key Takeaways 15.5.2.Asia Pacific mRNA Technology Market by Product 15.5.3.Asia Pacific mRNA Technology Market by Manufacturing 15.5.4.Asia Pacific mRNA Technology Market by Application 15.5.5.Asia Pacific mRNA Technology Market by End User 15.5.6.Asia Pacific mRNA Technology Market by Country 15.5.6.1. China 15.5.6.2. Japan 15.5.6.3. India 15.5.6.4. South Korea 15.5.6.5. Australia 15.5.6.6. ASEAN 15.5.6.7. Rest of Asia-Pacific 15.6.Middle East & Africa mRNA Technology Market Analysis and Forecast 2020-2030 15.6.1.Regional Market Overview and Key Takeaways Click here to purchase online!

  5. Global mRNA Technology Market Investment, Market Size & Forecast, 2020-2030 15.6.2.Middle East & Africa mRNA Technology Market by Product 15.6.3.Middle East & Africa mRNA Technology Market by Manufacturing 15.6.4.Middle East & Africa mRNA Technology Market by Application 15.6.5.Middle East & Africa mRNA Technology Market by End User 15.6.6.Middle East & Africa mRNA Technology Market by Country 15.6.6.1. GCC 15.6.6.2. South Africa 15.6.6.3. Turkey 15.6.6.4. Rest of the Middle East & Africa 16.Competitive Landscape 16.1.Competition Dashboard 16.1.1.Global and Regional Market Share Analysis 16.1.2.Market Structure 16.2.Competitive Benchmarking 16.3.Key Strategy Analysis 16.4.Company Profiles 16.4.1.Moderna Therapeutics 16.4.1.1. Company Overview 16.4.1.2. Product/Service Offerings 16.4.1.3. Key Financials 16.4.1.4. Recent Developments 16.4.2.BioNTech SE 16.4.2.1. Company Overview 16.4.2.2. Product/Service Offerings 16.4.2.3. Key Financials 16.4.2.4. Recent Developments 16.4.3.Ethris GmbH 16.4.3.1. Company Overview 16.4.3.2. Product/Service Offerings 16.4.3.3. Key Financials 16.4.3.4. Recent Developments 16.4.4.AstraZeneca Plc 16.4.4.1. Company Overview 16.4.4.2. Product/Service Offerings 16.4.4.3. Financials 16.4.4.4. Recent Developments 16.4.5.CureVac AG 16.4.5.1. Company Overview 16.4.5.2. Product/Service Offerings 16.4.5.3. Financials 16.4.5.4. Recent Developments 16.4.6.Argos Therapeutics, Inc. 16.4.6.1. Company Overview 16.4.6.2. Product/Service Offerings 16.4.6.3. Financials 16.4.6.4. Recent Developments 16.4.7.Sangamo Therapeutics Inc. 16.4.7.1. Company Overview Click here to purchase online!

  6. Global mRNA Technology Market Investment, Market Size & Forecast, 2020-2030 16.4.7.2. Product/Service Offerings 16.4.7.3. Financials 16.4.7.4. Recent Developments 16.4.8.Pfizer Inc. 16.4.8.1. Company Overview 16.4.8.2. Product/Service Offerings 16.4.8.3. Financials 16.4.8.4. Recent Developments 16.4.9.Biocon Ltd. 16.4.9.1. Company Overview 16.4.9.2. Product/Service Offerings 16.4.9.3. Financials 16.4.9.4. Recent Developments 16.4.10.Tiba Biotechnology 16.4.10.1. Company Overview 16.4.10.2. Product/Service Offerings 16.4.10.3. Financials 16.4.10.4. Recent Developments 16.4.11.Verve Therapeutics Inc. 16.4.11.1. Company Overview 16.4.11.2. Product/Service Offerings 16.4.11.3. Financials 16.4.11.4. Recent Developments 16.4.12.Takeda Pharmaceutical Co, Ltd. 16.4.12.1. Company Overview 16.4.12.2. Product/Service Offerings 16.4.12.3. Financials 16.4.12.4. Recent Developments 16.4.13.Intellia Therapeutics Inc. 16.4.13.1. Company Overview 16.4.13.2. Product/Service Offerings 16.4.13.3. Financials 16.4.13.4. Recent Developments 16.4.14.Kernal Biologics Inc. 16.4.14.1. Company Overview 16.4.14.2. Product/Service Offerings 16.4.14.3. Financials 16.4.14.4. Recent Developments *List not exhaustive (Players can be added or replaced as per the customization) 17.Disclaimer Click here to purchase online!

  7. Global mRNA Technology Market Investment, Market Size & Forecast, 2020-2030 A growing number of investments in R&D activities will be a driving factor for market growth. Proliferation of investment in R&D North America dominated market revenue in 2021 The rise in the prevalence of medical conditions like diabetes, tuberculosis (TB), cancer, and cardiovascular diseases (CVDs) coupled with the promising results of mRNA technology in treating these medical disorders is likely to augment the demand for mRNA technology. The industry also benefits from the increasing demand for vaccines and therapeutic drugs that treat COVID-19, Ebola, and influenza chronic and infectious diseases like HIV and other viral diseases. Pharma companies have invested in the mRNA process since it allows them to blend many molecules to create therapeutic drugs, technological breakthroughs, and extensive Source: RationalStat Analysis North America to remain key region Market structure and competitive landscape North America has enormous growth potential due to the massive number of key players and the rapid growth in the number of people within the US. Additionally, the increase in investment and R&D efforts, a rising interest in developing novel therapeutics and precision medicine, a suitable regulatory framework, and a rising demand for transformative treatments are all factors in expanding the market across North America. Players operating in the global mRNA technology market are focused on investing in mRNA technology which allows them to numerous molecules into a therapeutic drug. Players are adopting various strategies to gain a competitive edge and first- mover advantage in the market. Some prominent players contributing significantly to the market growth include Moderna Therapeutics, BioNTech, Ethris, CureVac, Argos Therapeutics, Sangamo Therapeutics Inc., Pfizer Inc, Biocon, Tiba Biotechnology, Verve Therapeutics Ltd. and many more. Oncology holds a prominent share The rising incidence of cancer is predicted to create significant growth opportunities for the market. According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, responsible for about 10 million mortalities in 2020. Infections that cause cancer, such as human papillomavirus, hepatitis, and hepatitis responsible for 30% of cancer-related deaths in lower and middle-income countries. Click here to purchase online!

  8. Global mRNA Technology Market Investment, Market Size & Forecast, 2020-2030 Global mRNA Technology Market Analysis & Forecast by Application, 2020-2030 (US$ Million) Breakup by Breakup by Application Application 2020(H) 2020(H) 2021(H) 2021(H) 2022(E) 2022(E) 2023(F) 2023(F) 2024(F) 2024(F) 2025(F) 2025(F) 2026(F) 2026(F) 2027(F) 2027(F) 2028(F) 2028(F) 202 2029 9(F) (F) 20 2030 30(H) (H) XX XX XX XX XX XX XX XX XX XX XX Oncology Respiratory Diseases XX XX XX XX XX XX XX XX XX XX XX Infectious Diseases XX XX XX XX XX XX XX XX XX XX XX Rare Diseases XX XX XX XX XX XX XX XX XX XX XX Others (coronary artery diseases, etc.) XX XX XX XX XX XX XX XX XX XX XX Total Total XX XX XX XX XX XX XX XX XX XX XX Global mRNA Technology Market Breakup by Region, 2022 (%) XX% XX% XX% XX% XX% XX% Click here to purchase online!

  9. Global mRNA Technology Market Investment, Market Size & Forecast, 2020-2030 Sources considered for the report Primary Sources •Extensive primary interviews were conducted during the research study. Over 120 industry specialists were contacted while conducting the research study to gather market insights. The primary interviews have been conducted with specialists across the value chain ranging from the service providers to end users, across the globe. Secondary Sources •Annual reports, company filings, investor presentations, product catalogs, white papers, research reports, trade fairs, Robotic Industries Association, International Federation of Robotics, and company documents. •Available industry and market-related documents in the public domain. •Paid database including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, Thomson Reuters, among others. •Whitepapers, research papers, and industry blogs Why buy this report? The report provides an in-depth analysis of market size, consumption pattern, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions. The report is intended for healthcare & life sciences companies, pharmaceutical companies, research organizations, government organizations, educational organizations, regulatory agencies, and market research firms, among others. About RationalStat LLC RationalStat is a global market intelligence partner dedicated to offer in-depth insight and recommendations to a varied clientele of medium and large-sized corporations. We provide cost-effective, accurate, and insightful business intelligence to our clients within tight timeframes. We offer a host of comprehensive market research reports, industry trackers, macroeconomic research, and subscription services, covering many sectors. Our team of accomplished sectoral analysts, economists, and industry specialists produce comprehensive analysis and rigorous market studies to guide investment decisions and growth strategies. For Procurement, unlike many other research solutions on the market today, RationalStat caters directly to procurement professionals. Our research follows a consistent table of contents, meaning you can easily find what you need. Contact us RationalStat LLC 2055 Limestone Rd STE 200-C, Wilmington, DE 19808, USA Web: rationalstat.com Call: +1 302-803-5429 Email: info@rationalstat.com Click here to purchase online!

More Related